Loading…
Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives
The polyphenolic compound (−)-epigallocatechin-3-gallate (EGCG) is the major catechin found in green tea and is thought to impart many of the health benefits attributed to this beverage. The latest clinical studies have supported some of the potential health benefits of consuming green tea and EGCG....
Saved in:
Published in: | Phytochemistry (Oxford) 2006-09, Vol.67 (17), p.1849-1855 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The polyphenolic compound (−)-epigallocatechin-3-gallate (EGCG) is the major catechin found in green tea and is thought to impart many of the health benefits attributed to this beverage. The latest clinical studies have supported some of the potential health benefits of consuming green tea and EGCG. The results from significant clinical studies and the most recent work in the area of stereoselective EGCG synthesis are described.
The compound (−)-epigallocatechin-3-gallate (EGCG) is the major catechin found in green tea [
Camellia sinensis L. Ktze. (Theaceae)]. This polyphenolic compound and several related catechins are believed to be responsible for the health benefits associated with the consumption of green tea. The potential health benefits ascribed to green tea and EGCG include antioxidant effects, cancer chemoprevention, improving cardiovascular health, enhancing weight loss, protecting the skin from the damage caused by ionizing radiation, and others. The compound EGCG has been shown to regulate dozens of disease-specific molecular targets. Many of these molecular targets are only affected by concentrations of EGCG that are far above the levels achieved by either drinking green tea or consuming moderate doses of green tea extract-based dietary supplements. In spite of this, well-designed double-blinded controlled clinical studies have recently demonstrated the efficacy of green tea extracts and purified EGCG products in patients. Therefore, this review highlights results from what the authors believe to be some of the most clinically significant recent studies and describes current developments in the stereoselective total synthesis of EGCG. |
---|---|
ISSN: | 0031-9422 1873-3700 |
DOI: | 10.1016/j.phytochem.2006.06.020 |